JTE-907

• Description:

  JTE-907 is a highly selective, orally active CB2 receptor inverse agonist and exerts anti-inflammatory effects in vivo[1].

• UNSPSC:

  12352005

• Hazard Statement:

  H302

• Target:

  Cannabinoid Receptor

• Type:

  Reference compound

• Related Pathways:

  GPCR/G Protein; Neuronal Signaling

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/jte-907.html

• Purity:

  98.72

• Solubility:

  DMSO : 125 mg/mL (ultrasonic)

• Smiles:

  O=C(C1=CC2=C(NC1=O)C(OCCCCC)=C(OC)C=C2)NCC3=CC=C(OCO4)C4=C3

• Molecular Formula:

  C24H26N2O6

• Molecular Weight:

  438.47

• Precautions:

  H302

• References & Citations:

  [1]Ueda Y, et al. Involvement of cannabinoid CB (2) receptor-mediated response and efficacy of cannabinoid CB (2) receptor inverse agonist, JTE-907, in cutaneous inflammation in mice. Eur J Pharmacol. 2005 Sep 27;520 (1-3) :164-71.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  4°C (Powder, stored under nitrogen)

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [282089-49-0]